Patents/Assignees

ENLITISA (SHANGHAI) PHARMACEUTICAL CO., Ltd.

4 patents in portfolio

US12612430utility2026
Peptides
0 cites
US12129313utility2024
Anti-inflammatory Use of Peptide
0 cites
US11680082utility2023
Conjugates of Montelukast and Peptides
0 cites
US11672792utility2023
Topical Formulations Comprising Montelukast and Combinations with Mussel Adhesive Proteins
0 cites